Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction—a phase I pilot clinical trial: study protocol

Lignende værker

• Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol
  af: Hobson, Sebastian R, et al.
  Udgivet: (2013)
• Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction
  af: Palmer, Kirsten R, et al.
  Udgivet: (2019)
• Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea
  af: Hincker, Alex, et al.
  Udgivet: (2021)
• A pilot double-blind randomised placebo-controlled dose–response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol
  af: Fernando, Shavi, et al.
  Udgivet: (2014)
• Maternal Antioxidant Status in Early Pregnancy and Development of Fetal Complications in Twin Pregnancies: A Pilot Study
  af: David Ramiro-Cortijo, et al.
  Udgivet: (2020-03-01)